Elekta AB Long Term Debt 2013-2023 | EKTAY
Elekta AB long term debt from 2013 to 2023. Long term debt can be defined as the sum of all long term debt fields.
| Elekta AB Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $546 |
| 2022 | $462 |
| 2021 | $348 |
| 2020 | $737 |
| 2019 | $394 |
| 2018 | $527 |
| 2017 | $603 |
| 2016 | $364 |
| 2015 | $667 |
| 2014 | $669 |
| 2013 | $651 |
| 2012 | $671 |
| Elekta AB Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-07-31 | $546 |
| 2023-04-30 | $546 |
| 2023-01-31 | $397 |
| 2022-10-31 | $383 |
| 2022-07-31 | $407 |
| 2022-04-30 | $462 |
| 2022-01-31 | $513 |
| 2021-10-31 | $352 |
| 2021-07-31 | $363 |
| 2021-04-30 | $348 |
| 2021-01-31 | $588 |
| 2020-10-31 | $567 |
| 2020-07-31 | $744 |
| 2020-04-30 | $737 |
| 2020-01-31 | $278 |
| 2019-10-31 | $323 |
| 2019-07-31 | $370 |
| 2019-04-30 | $394 |
| 2019-01-31 | $495 |
| 2018-10-31 | $490 |
| 2018-07-31 | $494 |
| 2018-04-30 | $527 |
| 2018-01-31 | $506 |
| 2017-10-31 | $584 |
| 2017-07-31 | $542 |
| 2017-04-30 | $603 |
| 2017-01-31 | $355 |
| 2016-10-31 | $382 |
| 2016-07-31 | $383 |
| 2016-04-30 | $364 |
| 2016-01-31 | $587 |
| 2015-10-31 | $597 |
| 2015-07-31 | $603 |
| 2015-04-30 | $667 |
| 2015-01-31 | $515 |
| 2014-10-31 | $524 |
| 2014-07-31 | $683 |
| 2014-04-30 | $669 |
| 2014-01-31 | $665 |
| 2013-10-31 | $664 |
| 2013-07-31 | $658 |
| 2013-04-30 | $651 |
| 2013-01-31 | $647 |
| 2012-10-31 | $659 |
| 2012-07-31 | $632 |
| 2012-04-30 | $671 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.766B | $1.614B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.088B | 26.31 |
| Intuitive Surgical (ISRG) | United States | $131.461B | 79.19 |
| Edwards Lifesciences (EW) | United States | $51.022B | 33.20 |
| DexCom (DXCM) | United States | $50.661B | 76.74 |
| IQVIA Holdings (IQV) | United States | $42.066B | 24.95 |
| IDEXX Laboratories (IDXX) | United States | $40.926B | 48.93 |
| Alcon (ALC) | Switzerland | $38.255B | 28.21 |
| STERIS (STE) | Ireland | $20.213B | 23.92 |
| Waters (WAT) | United States | $18.329B | 26.30 |
| Hologic (HOLX) | United States | $17.786B | 19.63 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.385B | 85.32 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.347B | 15.25 |
| Sysmex ADR (SSMXY) | Japan | $10.045B | 31.50 |
| Teleflex (TFX) | United States | $9.832B | 15.44 |
| Penumbra (PEN) | United States | $7.615B | 94.00 |
| Masimo (MASI) | United States | $7.112B | 39.88 |
| Globus Medical (GMED) | United States | $6.740B | 21.37 |
| Glaukos (GKOS) | United States | $4.818B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.740B | 22.60 |
| TransMedics (TMDX) | United States | $3.079B | 294.16 |
| LivaNova (LIVN) | United Kingdom | $3.019B | 19.84 |
| PROCEPT BioRobotics (PRCT) | United States | $2.723B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.442B | 20.65 |
| Tandem Diabetes Care (TNDM) | United States | $2.369B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.293B | 9.41 |
| Inari Medical (NARI) | United States | $2.164B | 0.00 |
| RxSight (RXST) | United States | $1.938B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.764B | 0.00 |
| Veracyte (VCYT) | United States | $1.496B | 0.00 |
| OPKO Health (OPK) | United States | $0.850B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.835B | 15.45 |
| Artivion (AORT) | United States | $0.808B | 93.43 |
| Silk Road Medical (SILK) | United States | $0.767B | 0.00 |
| Paragon 28 (FNA) | United States | $0.764B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.705B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.640B | 0.00 |
| SiBone (SIBN) | United States | $0.588B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.572B | 19.43 |
| IRadimed (IRMD) | United States | $0.514B | 29.86 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.407B | 0.00 |
| Nevro (NVRO) | United States | $0.388B | 0.00 |
| NeuroPace (NPCE) | United States | $0.373B | 0.00 |
| CVRx (CVRX) | United States | $0.335B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.327B | 11.02 |
| AxoGen (AXGN) | United States | $0.280B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.275B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.261B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| Accuray (ARAY) | United States | $0.211B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| 908 Devices (MASS) | United States | $0.188B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.180B | 9.67 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.144B | 0.00 |
| Neuronetics (STIM) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.099B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.083B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 125.33 |
| SEP Acquisition (SEPA) | United States | $0.061B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.061B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.052B | 9.42 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| DarioHealth (DRIO) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.019B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |